Zepbound vs Wegovy trial and compounded GLP-1s

Dec 9, 2024 · 44 min · Episode 104 · 42.5 MB

0:00-44:15

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.

Learn:

Weight loss and glycemic differences between tirzepatide and semaglutide

What the FDA is thinking for compounded GLP-1s

If you're not on Dr. Spencer's virtual clinic waitlist, click here

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.